{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:24:39Z","timestamp":1755692679764,"version":"3.40.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00406-024-01832-w","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T20:31:32Z","timestamp":1719865892000},"page":"365-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cannabis-related treatment demand at the eve of German cannabis legalization \u2013 a 20-years trend analysis"],"prefix":"10.1007","volume":"275","author":[{"given":"Alisa","family":"Stampf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-7700","authenticated-orcid":false,"given":"Larissa","family":"Schwarzkopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-5121","authenticated-orcid":false,"given":"Albert","family":"Batalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3635-4586","authenticated-orcid":false,"given":"Daniel","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-4030","authenticated-orcid":false,"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Advisory Board of the German Addiction Care Statistical Service","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Bachmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"M\u00e4der-Linke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Egartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Raiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Timmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Sauermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"1832_CR1","unstructured":"UNODC, World Drug Report (2023) United Nations publication. https:\/\/www.unodc.org\/res\/WDR-2023\/WDR23_Exsum_fin_DP.pdf. Accessed 17 Apr 2024"},{"key":"1832_CR2","unstructured":"United Nations publication, Sales No. E.21.XI.8. https:\/\/www.unodc.org\/res\/wdr2021\/field\/WDR21_Booklet_2.pdf. Accessed 17 Apr 2024"},{"key":"1832_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.drugpo.2019.03.006","volume":"68","author":"J Manthey","year":"2019","unstructured":"Manthey J (2019) Cannabis use in Europe: current trends and public health concerns. Int J Drug Policy 68:93\u201396. https:\/\/doi.org\/10.1016\/j.drugpo.2019.03.006","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1832_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/add.16356","volume":"119","author":"S Olderbak","year":"2024","unstructured":"Olderbak S et al (2024) Trends and projection in the proportion of (heavy) cannabis use in Germany from 1995 to 2021. Addiction 119(2):311\u2013321. https:\/\/doi.org\/10.1111\/add.16356","journal-title":"Addiction"},{"issue":"31\u201332","key":"1832_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3238\/arztebl.m2022.0244","volume":"119","author":"C Rauschert","year":"2022","unstructured":"Rauschert C et al (2022) The use of psychoactive substances in Germany: findings from the epidemiological survey of substance abuse 2021. Dtsch Arztebl Int 119(31\u201332):527\u2013534. https:\/\/doi.org\/10.3238\/arztebl.m2022.0244","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"1832_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","volume":"7","author":"JP Connor","year":"2021","unstructured":"Connor JP et al (2021) Cannabis use and cannabis use disorder. Nat Rev Dis Primers 7(1):16. https:\/\/doi.org\/10.1038\/s41572-021-00247-4","journal-title":"Nat Rev Dis Primers"},{"key":"1832_CR7","unstructured":"APA, Diagnostic and statistical manual of mental disorders (5th ed.). 2013, Arlington, VA: American Psychiatric Association."},{"issue":"16","key":"1832_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3238\/arztebl.2015.0271","volume":"112","author":"E Hoch","year":"2015","unstructured":"Hoch E et al (2015) Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int 112(16):271\u2013278. https:\/\/doi.org\/10.3238\/arztebl.2015.0271","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"1832_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jaac.2016.12.014","volume":"56","author":"A Levine","year":"2017","unstructured":"Levine A et al (2017) Evidence for the risks and consequences of adolescent cannabis exposure. J Am Acad Child Adolesc Psychiatry 56(3):214\u2013225. https:\/\/doi.org\/10.1016\/j.jaac.2016.12.014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"1832_CR10","doi-asserted-by":"publisher","first-page":"Cd005336","DOI":"10.1002\/14651858.CD005336.pub4","volume":"2016","author":"PJ Gates","year":"2016","unstructured":"Gates PJ et al (2016) Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev 2016(5):Cd005336. https:\/\/doi.org\/10.1002\/14651858.CD005336.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"1832_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100227","volume":"10","author":"J Manthey","year":"2021","unstructured":"Manthey J et al (2021) Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. Lancet Reg Health Eur 10:100227. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100227","journal-title":"Lancet Reg Health Eur"},{"key":"1832_CR12","doi-asserted-by":"publisher","first-page":"107049","DOI":"10.1016\/j.addbeh.2021.107049","volume":"123","author":"J Mennis","year":"2021","unstructured":"Mennis J, Stahler GJ, McKeon TP (2021) Young adult cannabis use disorder treatment admissions declined as past month cannabis use increased in the U.S.: an analysis of states by year, 2008\u20132017. Addictive Behav 123:107049. https:\/\/doi.org\/10.1016\/j.addbeh.2021.107049","journal-title":"Addictive Behav"},{"key":"1832_CR13","doi-asserted-by":"publisher","first-page":"E145","DOI":"10.5888\/pcd17.200156","volume":"17","author":"J Mennis","year":"2020","unstructured":"Mennis J (2020) Trends in adolescent treatment admissions for Marijuana in the United States, 2008\u20132017. Prev Chronic Dis 17:E145. https:\/\/doi.org\/10.5888\/pcd17.200156","journal-title":"Prev Chronic Dis"},{"key":"1832_CR14","unstructured":"Deutscher Bundestag, [Legalisation of Cannabis: effects on the number of consumers in selected countries]. 2019: https:\/\/www.bundestag.de\/resource\/blob\/675688\/4ba9aed6de8e9633685a1cdc2d823525\/WD-9-072-19-pdf-data.pdf. Accessed 17 Apr 2024"},{"key":"1832_CR15","unstructured":"Deutsche Hauptstelle f\u00fcr Suchtfragen, [The supply of people with substance abuse problems in Germany. Analysis on support and supply and future perspectives.]. Update, 2019. Accessed 17 Apr 2024"},{"key":"1832_CR16","unstructured":"Deutsche Hauptstelle f\u00fcr Suchtfragen (DHS), [German Core Dataset for documentation in the drug treatment sector. Definitions and explanations for usage]. 2001, Hamm"},{"key":"1832_CR17","unstructured":"Deutsche Hauptstelle f\u00fcr Suchtfragen (DHS), [German Core Dataset for documentation in the drug treatment sector. Definitions and explanations for usage]. 2007, Hamm"},{"key":"1832_CR18","unstructured":"Deutsche Hauptstelle f\u00fcr Suchtfragen (DHS), [German Core Dataset for documentation in the drug treatment sector 3.0\u2014definitions and explanations for usage]. 2018: Hamm"},{"key":"1832_CR19","unstructured":"Hildebrand, A., et al., [Supply of people with substance abuse problems in Germany: results of the Statistical Report on Substance Abuse Treatment in Germany (DSHS) 2007]. IFT Institut f\u00fcr Therapieforschung, 2008"},{"key":"1832_CR20","unstructured":"Thaller, R., et al., [Substance Abuse Treatment in Germany 2016]. IFT Institut f\u00fcr Therapieforschung, 2017"},{"key":"1832_CR21","unstructured":"Dauber, H., et al., [Substance abuse treatment in Germany 2017]. IFT Institut f\u00fcr Therapieforschung, 2018"},{"key":"1832_CR22","unstructured":"Schwarzkopf, L., et al. Die Deutsche Suchthilfestatistik\u2014DSHS. Eine Einf\u00fchrung in Datenerfassung, Datensammlung, Datenverarbeitung und Auswertungen. Konturen online. Fachportal zu Sucht und sozialen Fragen, 2020"},{"issue":"02","key":"1832_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/s-0034-1396815","volume":"77","author":"E Swart","year":"2015","unstructured":"Swart E et al (2015) Good practice analyses of secondary data: guidelines and recommendations]. Gesundheitswesen 77(02):120\u2013126. https:\/\/doi.org\/10.1055\/s-0034-1396815","journal-title":"Gesundheitswesen"},{"key":"1832_CR24","unstructured":"Schwarzkopf, L., et al., [Substance abuse treatment in Germany 2020]. IFT Institut f\u00fcr Therapieforschung, 2021"},{"key":"1832_CR25","unstructured":"Steppan, M., J. K\u00fcnzel, and T. Pfeiffer-Gerschel, [Substance abuse treatment in Germany 2010]. IFT Institut f\u00fcr Therapieforschung, 2011"},{"issue":"1","key":"1832_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1024\/2009.01.15","volume":"55","author":"B S\u00fcss","year":"2009","unstructured":"S\u00fcss B, Pfeiffer-Gerschel T (2009) The DBDD facility register: background, objectives and current status. SUCHT 55(1):59\u201360. https:\/\/doi.org\/10.1024\/2009.01.15","journal-title":"SUCHT"},{"key":"1832_CR27","unstructured":"National Cancer Institute, Joinpoint Statistical Software version 4.9.1.0. 2021"},{"key":"1832_CR28","unstructured":"National Cancer Institute. Statistical Methodology and Applicacations Branch. Surveillance Research Program. Bethesda, MD: NCI Joinpoint Regression Program. 2022; Available from: https:\/\/surveillance.cancer.gov\/joinpoint\/. Accessed 17 Apr 2024"},{"issue":"3","key":"1832_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ et al (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335\u2013351. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(20000215)19:3%3c335::AID-SIM336%3e3.0.CO;2-Z","journal-title":"Stat Med"},{"key":"1832_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02515","volume":"5","author":"D Gillis","year":"2019","unstructured":"Gillis D, Edwards B (2019) The utility of joinpoint regression for estimating population parameters given changes in population structure. Heliyon 5:e02515. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02515","journal-title":"Heliyon"},{"issue":"3","key":"1832_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.15288\/jsad.2017.78.344","volume":"78","author":"C Chapman","year":"2017","unstructured":"Chapman C et al (2017) Evidence for sex convergence in prevalence of cannabis use: a systematic review and meta-regression. J Stud Alcohol Drugs 78(3):344\u2013352. https:\/\/doi.org\/10.15288\/jsad.2017.78.344","journal-title":"J Stud Alcohol Drugs"},{"key":"1832_CR32","unstructured":"Rauschert C, et al., [Short report Epidemiological Survey of Substance Use 2021. Volume of tables: trends in the prevalence of (problematic) illicit drug use by sex and age 1990\u20132021]. IFT Institut f\u00fcr Therapieforschung, 2023"},{"key":"1832_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17020509","author":"L Greaves","year":"2020","unstructured":"Greaves L, Hemsing N (2020) Sex and gender interactions on the use and impact of recreational cannabis. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph17020509","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1832_CR34","first-page":"55","volume":"29","author":"CA Green","year":"2006","unstructured":"Green CA (2006) Gender and use of substance abuse treatment services. Alcohol Res Health 29(1):55\u201362","journal-title":"Alcohol Res Health"},{"key":"1832_CR35","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2016.18.4\/jbecker","author":"JB Becker","year":"2022","unstructured":"Becker JB (2022) Sex differences in addiction. Dialog Clin Neurosci. https:\/\/doi.org\/10.31887\/DCNS.2016.18.4\/jbecker","journal-title":"Dialog Clin Neurosci"},{"key":"1832_CR36","doi-asserted-by":"publisher","DOI":"10.17623\/BZGA:Q3-ALKSY21-DE-1.0","author":"B Orth","year":"2022","unstructured":"Orth B, Merkel C (2022) The substance use of adolescents and young adults in Germany. Results of the Alcohol Survey 2021 on alcohol, smoking, cannabis and trends BZgA-research report. K\u00f6ln: Bundeszentrale f\u00fcr Gesundheitliche Aufkl\u00e4rung. https:\/\/doi.org\/10.17623\/BZGA:Q3-ALKSY21-DE-1.0","journal-title":"K\u00f6ln: Bundeszentrale f\u00fcr Gesundheitliche Aufkl\u00e4rung."},{"issue":"6","key":"1832_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/00952990.2019.1569668","volume":"45","author":"DS Hasin","year":"2019","unstructured":"Hasin DS, Shmulewitz D, Sarvet AL (2019) Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. Am J Drug Alcohol Abuse 45(6):623\u2013643. https:\/\/doi.org\/10.1080\/00952990.2019.1569668","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"04","key":"1832_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/a-0847-9296","volume":"22","author":"E Hoch","year":"2021","unstructured":"Hoch E, Preuss UW (2021) Cannabis, cannabinoids and cannabis use disorder. Suchttherapie 22(04):203\u2013216. https:\/\/doi.org\/10.1055\/a-0847-9296","journal-title":"Suchttherapie"},{"issue":"3","key":"1832_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1369-1600.2011.00417.x","volume":"18","author":"J Cousijn","year":"2013","unstructured":"Cousijn J et al (2013) Neural responses associated with cue-reactivity in frequent cannabis users. Addict Biol 18(3):570\u2013580. https:\/\/doi.org\/10.1111\/j.1369-1600.2011.00417.x","journal-title":"Addict Biol"},{"issue":"3","key":"1832_CR40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1037\/pha0000456","volume":"29","author":"JD Buckner","year":"2021","unstructured":"Buckner JD, Morris PE, Zvolensky MJ (2021) Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use. Exp Clin Psychopharmacol 29(3):272\u2013278. https:\/\/doi.org\/10.1037\/pha0000456","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"1832_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00406-018-0976-1","volume":"269","author":"AJ Budney","year":"2019","unstructured":"Budney AJ, Sofis MJ, Borodovsky JT (2019) An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. Eur Arch Psychiatry Clin Neurosci 269(1):73\u201386. https:\/\/doi.org\/10.1007\/s00406-018-0976-1","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"1832_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000475810","volume":"23","author":"L Montanari","year":"2017","unstructured":"Montanari L et al (2017) Cannabis use among people entering drug treatment in Europe: a growing phenomenon? Eur Addict Res 23(3):113\u2013121. https:\/\/doi.org\/10.1159\/000475810","journal-title":"Eur Addict Res"},{"key":"1832_CR43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.drugalcdep.2019.02.003","volume":"197","author":"J Burdzovic Andreas","year":"2019","unstructured":"Burdzovic Andreas J (2019) Perceived harmfulness of various alcohol- and cannabis use modes: secular trends, differences, and associations with actual substance use behaviors among Norwegian adolescents, 2007\u20132015. Drug Alcohol Depend 197:280\u2013287. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.003","journal-title":"Drug Alcohol Depend"},{"key":"1832_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.107091","volume":"124","author":"JT Waddell","year":"2022","unstructured":"Waddell JT (2022) Age-varying time trends in cannabis- and alcohol-related risk perceptions 2002\u20132019. Addict Behav 124:107091. https:\/\/doi.org\/10.1016\/j.addbeh.2021.107091","journal-title":"Addict Behav"},{"issue":"9","key":"1832_CR45","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1111\/jgs.17213","volume":"69","author":"BH Han","year":"2021","unstructured":"Han BH et al (2021) Decreasing perceived risk associated with regular cannabis use among older adults in the United States from 2015 to 2019. J Am Geriatr Soc 69(9):2591\u20132597. https:\/\/doi.org\/10.1111\/jgs.17213","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1832_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s40429-022-00461-4","volume":"10","author":"J Mennis","year":"2023","unstructured":"Mennis J, Stahler GJ, Mason MJ (2023) Cannabis legalization and the decline of cannabis use disorder (CUD) treatment utilization in the US. Curr Addict Rep 10(1):38\u201351. https:\/\/doi.org\/10.1007\/s40429-022-00461-4","journal-title":"Curr Addict Rep"},{"issue":"Pt A","key":"1832_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109154","volume":"229","author":"MS Askari","year":"2021","unstructured":"Askari MS, Keyes KM, Mauro PM (2021) Cannabis use disorder treatment use and perceived treatment need in the United States: time trends and age differences between 2002 and 2019. Drug Alcohol Depend 229(Pt A):109154. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109154","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1832_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/adm.0000000000001219","volume":"17","author":"J Mennis","year":"2023","unstructured":"Mennis J, Stahler GJ, McKeon TP (2023) Criminal justice referrals to cannabis use disorder treatment among adolescents and young adults following recreational cannabis legalization in the United States. J Addict Med 17(6):725\u2013728. https:\/\/doi.org\/10.1097\/adm.0000000000001219","journal-title":"J Addict Med"},{"issue":"6","key":"1832_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.clinthera.2023.03.006","volume":"45","author":"KN Harris","year":"2023","unstructured":"Harris KN, Kulesza C (2023) Exploring the impact of adult-use cannabis legalization on legal system referrals to treatment for cannabis use: do age and race have a moderating effect? Clin Ther 45(6):599\u2013615. https:\/\/doi.org\/10.1016\/j.clinthera.2023.03.006","journal-title":"Clin Ther"},{"key":"1832_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drugalcdep.2017.09.032","volume":"181","author":"BT Kerridge","year":"2017","unstructured":"Kerridge BT et al (2017) Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. Drug Alcohol Depend 181:223\u2013228. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.09.032","journal-title":"Drug Alcohol Depend"},{"key":"1832_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.addbeh.2016.03.033","volume":"59","author":"SF Babbin","year":"2016","unstructured":"Babbin SF et al (2016) Identifying treatment response subgroups for adolescent cannabis use. Addict Behav 59:72\u201379. https:\/\/doi.org\/10.1016\/j.addbeh.2016.03.033","journal-title":"Addict Behav"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-024-01832-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-024-01832-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-024-01832-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T20:09:55Z","timestamp":1743106195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-024-01832-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s00406-024-01832-w","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"type":"print","value":"0940-1334"},{"type":"electronic","value":"1433-8491"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BF held research grants and contracts in the areas of substance use, health and policy from public funding, government, and not-for-profit organizations (i.e., non-commercial-only sources). All other authors declare, that over the period of the most recent three years they do not have any financial or immaterial competing interests directly or indirectly related to the work submitted for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}